NPA says 'arbitrary' new FDA protein definition could have implications for industry
The Natural Products Association has filed a comment on a proposed FDA rule that would define protein in what the organization calls an arbitrary way.
Archives for February 28, 2019
Gottlieb: FDA plans meeting in April on new CBD regulations
FDA Commissioner Dr. Scott Gottlieb said the agency is planning a public meeting in April to initiate a rule making procedure on CBD. The goal is to create “an appropriately efficient and predictable regulatory framework for regulating CBD products,” he...
New JAMA study supports importance of prenatal supplementation
Prenatal vitamin supplementation may be associated with a decreased prevalence of autism in children from high-risk families, according to a new study in JAMA Psychiatry.
Webinar recording available on-demand
On Demand: Demystify the detox organ at our liver health webinar
What’s the science behind ingredients used in supplements to support liver health? And what is the best way to market this to consumers? These are some topics we explored during our Liver Health webinar.
Inter-species communication? New study shows gut bacteria can control our genes and development
Bacteria in our guts may be impacting human health and disease by telling host genes what to do, say researchers who have uncovered a new mechanism by which our microbiome communicates with and controls the DNA of our own cells.
DuPont partner with Lonza in HMO-focused infant nutrition venture
DuPont Nutrition & Health and Lonza Consumer Health & Nutrition are to join forces to manufacture and supply human milk oligosaccharide (HMO) in a deal that looks to meet rising demand in a €44bn global infant nutrition sector.
NUTRAINGREDIENTS OMEGA-3 SUMMIT
Absorption enhancement: Australian human clinical trials show effectiveness of novel delivery method
The body's absorption of omega-3 increased by six times after taking a supplement that used the self micro-emulsifying delivery system (SMED) from Pharmako Biotechnologies, a series of human clinical trials conducted in Australia has found.